ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

ANTINEOPLASTIC AGENTS

PROTEIN KINASE INHIBITORS

BCR-ABL tyrosine kinase inhibitors

nilotinib

Ni podatka o razpoložljivosti zdravila

STADA Arzneimittel AG

Novo dovoljenje za promet

Nilotinib STADA 200 mg trde kapsule

Peroralna uporaba

Accessibility Statement

Advanced search

Name

Change history of medication data

Drug comparison

Composition and organoleptic properties

Changes to Terms

General

Limitation of Liability

Links to Other Sites

Terms of Use

Use of the Website

SmPC version comparison

SmPC chapters

Documents

Downloads

Pre-prepared medicine lists

Drug status

Filters

1. About the National Drug Registry

2. About the web application

3.1. Home page

3.2. Searching for data

3.3. Pre-prepared lists

3.4. Displaying the list of medicines

3.5. Displaying detailed information

3. Using the application

User Guide

National Drug Registry

News

Legend

Medicine name

Interchangeable medicines

The requested content does not exist or is no longer available. Please check the address or return to the home page.

Page not found

Privacy Policy

Search

Therapeutic group of medicines

Predpisovanje in izdaja zdravila je le na recept, zdravilo pa se uporablja samo v bolnišnicah. Izjemoma se lahko uporablja pri nadaljevanju zdravljenja na domu ob odpustu iz bolnišnice in nadaljnjem zdravljenju.

Blister

skupno pakiranje s 112 kapsulami (4 škatle z 28 kapsulami v PVC/PE/PVdC//Alu pretisnih omotih)

Nilotinib STADA 200 mg trde kapsule skupno pakiranje s 112 kapsulami (4 škatle z 28 kapsulami v PVC/PE/PVdC//Alu pretisnih omotih)

Safety features are present

nilotinib 200 mg, kapsula, trda